Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244525 · ClinicalTrials.gov registry record · Phase 4
Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT05244525: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT05244525 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244525, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.
Primary Outcome
This scale is scored from 1-10, a higher number indicating better clarity
Interventions
- DRUG Bupivacaine with Epinephrine
- DRUG Bupivacaine alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-08-31 |
| Phase | Phase 4 |
What the finished NCT05244525 record still lists
NCT05244525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine with Epinephrine is the first listed.
NCT05244525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05244525 about?
NCT05244525 is a clinical study titled "Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy". The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.
What is the current status of trial NCT05244525?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2022-03-14. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05244525?
The interventions under investigation include: Bupivacaine with Epinephrine (DRUG), Bupivacaine alone (DRUG).
Who is sponsoring clinical trial NCT05244525?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05244525's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI